November 7, 2023 | 12:00-1:00pm
After this training, the participant should feel more comfortable counseling their patients on the dangers of xylazine, a new compound that is in the white powder (opioids and stimulants) drug supply. This presentation emphasizes harm reduction in the setting of patients with substance use disorder, stressing that one can help someone who may not be ready for complete abstinence from harmful drug use.
- Appreciate appropriate use of xylazine and why it is not used in humans
- Learn the “street names” of xylazine
- Explore the prevalence of xylazine in Rhode Island
- Understand how to talk to your clients about xylazine
- Appreciate the subtle differences of what a xylazine overdose response should look like (specifically, when to use Naloxone and rescue breathing)
- Discuss wound care and safe injection practices to reduce harms from xylazine
Presenter: Cara Zimmerman, MD, MBA
Cara Zimmerman, MD, MBA, is the Medical Director of Primary Care Based Substance Use Disorder Treatment (MAT) for a federal qualified community health center in Rhode Island. She completed her Addiction Medicine and Internal Medicine training at Brown University and consults as part of the Opioid Response Network to teach colleagues about substance use disorder.
Prescribing clinicians and their teams
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and CCSME. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.
The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity qualifies for 1 credit of the 3 CME credit requirement for opioid medication education found in P.L. 2015, Chapter 488, Maine’s legislation to address the opioid drug crisis.
*Nurses and Nurse Practitioners will be awarded a certificate of participation with a maximum of 1 AMA PRA Category 1 Credit™.
1 contact hour for social workers, licensed clinical professional counselors, and behavioral health professionals.
1 contact hour for Alcohol and Drug Counselors pending approval by the Maine Board of Alcohol and Drug Counselors
1 Category I contact hour for psychologists. CCSME is a pre-approved sponsor and provider of Professional Education Activities for Psychologists.
1 contact hour CHES. CCSME is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.